vs
金罗斯黄金（GOLD）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是金罗斯黄金的1.4倍（$207.3M vs $148.1M），金罗斯黄金净利率更高（7.9% vs -62.0%，领先69.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -94.6%），金罗斯黄金自由现金流更多（$-46.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -76.2%）
金罗斯黄金公司是一家总部位于加拿大多伦多的金银开采企业，成立于1993年。目前公司共运营六座在产金矿，矿区分布在巴西、毛里塔尼亚与美国境内，在2019年InvestingNews评选的全球十大黄金开采企业中位列第五。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GOLD vs RARE — 直观对比
营收规模更大
RARE
是对方的1.4倍
$148.1M
营收增速更快
RARE
高出120.5%
-94.6%
净利率更高
GOLD
高出69.9%
-62.0%
自由现金流更多
GOLD
多$54.1M
$-100.8M
两年增速更快
RARE
近两年复合增速
-76.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $148.1M | $207.3M |
| 净利润 | $11.6M | $-128.6M |
| 毛利率 | 63.0% | — |
| 营业利润率 | 10.7% | -54.7% |
| 净利率 | 7.9% | -62.0% |
| 营收同比 | -94.6% | 25.9% |
| 净利润同比 | 77.4% | 3.5% |
| 每股收益（稀释后） | $0.46 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOLDRARE
| Q4 25 | $148.1M | $207.3M | ||
| Q3 25 | $3.7B | $159.9M | ||
| Q2 25 | $2.5B | $166.5M | ||
| Q1 25 | $3.0B | $139.3M | ||
| Q4 24 | $2.7B | $164.6M | ||
| Q3 24 | $2.7B | $139.5M | ||
| Q2 24 | $2.5B | $147.0M | ||
| Q1 24 | $2.6B | $108.8M |
净利润GOLDRARE
| Q4 25 | $11.6M | $-128.6M | ||
| Q3 25 | $-939.0K | $-180.4M | ||
| Q2 25 | $10.3M | $-115.0M | ||
| Q1 25 | $-8.5M | $-151.1M | ||
| Q4 24 | $6.6M | $-133.2M | ||
| Q3 24 | $9.0M | $-133.5M | ||
| Q2 24 | $30.9M | $-131.6M | ||
| Q1 24 | $5.0M | $-170.7M |
毛利率GOLDRARE
| Q4 25 | 63.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.3% | — |
营业利润率GOLDRARE
| Q4 25 | 10.7% | -54.7% | ||
| Q3 25 | -0.0% | -106.9% | ||
| Q2 25 | 0.5% | -64.8% | ||
| Q1 25 | -0.3% | -102.6% | ||
| Q4 24 | 0.3% | -74.3% | ||
| Q3 24 | 0.4% | -94.6% | ||
| Q2 24 | 1.3% | -79.1% | ||
| Q1 24 | 0.2% | -151.9% |
净利率GOLDRARE
| Q4 25 | 7.9% | -62.0% | ||
| Q3 25 | -0.0% | -112.8% | ||
| Q2 25 | 0.4% | -69.0% | ||
| Q1 25 | -0.3% | -108.5% | ||
| Q4 24 | 0.2% | -80.9% | ||
| Q3 24 | 0.3% | -95.7% | ||
| Q2 24 | 1.2% | -89.5% | ||
| Q1 24 | 0.2% | -156.8% |
每股收益（稀释后）GOLDRARE
| Q4 25 | $0.46 | $-1.28 | ||
| Q3 25 | $-0.04 | $-1.81 | ||
| Q2 25 | $0.43 | $-1.17 | ||
| Q1 25 | $-0.36 | $-1.57 | ||
| Q4 24 | $0.27 | $-1.34 | ||
| Q3 24 | $0.37 | $-1.40 | ||
| Q2 24 | $1.29 | $-1.52 | ||
| Q1 24 | $0.21 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $653.8M | $-80.0M |
| 总资产 | $3.8B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOLDRARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
股东权益GOLDRARE
| Q4 25 | $653.8M | $-80.0M | ||
| Q3 25 | $644.0M | $9.2M | ||
| Q2 25 | $649.5M | $151.3M | ||
| Q1 25 | $643.6M | $144.2M | ||
| Q4 24 | $612.7M | $255.0M | ||
| Q3 24 | $611.1M | $346.8M | ||
| Q2 24 | $607.6M | $432.4M | ||
| Q1 24 | $583.2M | $140.3M |
总资产GOLDRARE
| Q4 25 | $3.8B | $1.5B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $1.9B | $1.5B | ||
| Q3 24 | $2.0B | $1.5B | ||
| Q2 24 | $1.8B | $1.6B | ||
| Q1 24 | $1.7B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-42.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-46.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | -31.5% | -48.6% |
| 资本支出强度资本支出/营收 | 2.7% | 0.5% |
| 现金转化率经营现金流/净利润 | -3.66× | — |
| 过去12个月自由现金流最近4个季度 | $310.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流GOLDRARE
| Q4 25 | $-42.6M | $-99.8M | ||
| Q3 25 | $195.4M | $-91.4M | ||
| Q2 25 | $67.0M | $-108.3M | ||
| Q1 25 | $102.8M | $-166.5M | ||
| Q4 24 | $110.1M | $-79.3M | ||
| Q3 24 | $-127.5M | $-67.0M | ||
| Q2 24 | $82.8M | $-77.0M | ||
| Q1 24 | $79.8M | $-190.7M |
自由现金流GOLDRARE
| Q4 25 | $-46.6M | $-100.8M | ||
| Q3 25 | $193.4M | $-92.7M | ||
| Q2 25 | $63.1M | $-110.7M | ||
| Q1 25 | $100.4M | $-167.8M | ||
| Q4 24 | $106.4M | $-79.5M | ||
| Q3 24 | $-128.1M | $-68.6M | ||
| Q2 24 | $80.1M | $-79.0M | ||
| Q1 24 | $79.1M | $-193.9M |
自由现金流率GOLDRARE
| Q4 25 | -31.5% | -48.6% | ||
| Q3 25 | 5.3% | -58.0% | ||
| Q2 25 | 2.5% | -66.5% | ||
| Q1 25 | 3.3% | -120.5% | ||
| Q4 24 | 3.9% | -48.3% | ||
| Q3 24 | -4.7% | -49.2% | ||
| Q2 24 | 3.2% | -53.7% | ||
| Q1 24 | 3.0% | -178.2% |
资本支出强度GOLDRARE
| Q4 25 | 2.7% | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.0% | 3.0% |
现金转化率GOLDRARE
| Q4 25 | -3.66× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 6.49× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.78× | — | ||
| Q3 24 | -14.20× | — | ||
| Q2 24 | 2.68× | — | ||
| Q1 24 | 15.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GOLD
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
